| JPM SGD LIQUIDITY LVNAV C (ACC) | MONETARIO INTERNACIONAL - OTROS | 7.794,817645 | 19/02/2026 | 1,43% | 3,86% | ***** |
| JPM SGD LIQUIDITY LVNAV C (DIST) | MONETARIO INTERNACIONAL - OTROS | 0,670421 | 19/02/2026 | 1,27% | -4,59% | *** |
| JPM SGD LIQUIDITY LVNAV E (ACC) | MONETARIO INTERNACIONAL - OTROS | 7.463,998391 | 19/02/2026 | 1,45% | · | ND |
| JPM SGD LIQUIDITY LVNAV E (DIST) | MONETARIO INTERNACIONAL - OTROS | 0,670421 | 19/02/2026 | 1,27% | · | ND |
| JPM SGD LIQUIDITY LVNAV INSTITUTIONAL (DIST) | MONETARIO INTERNACIONAL - OTROS | 0,670421 | 19/02/2026 | 1,27% | -4,59% | *** |
| JPM TAIWAN A (ACC) EUR | RVI CHINA | 75,080000 | 11/02/2026 | 12,55% | 86,72% | ***** |
| JPM TAIWAN A (ACC) USD | RVI CHINA | 59,336134 | 11/02/2026 | 12,38% | 85,81% | ***** |
| JPM TAIWAN A (DIST) USD | RVI CHINA | 42,462185 | 11/02/2026 | 12,37% | 79,17% | ***** |
| JPM TAIWAN C (ACC) USD | RVI CHINA | 77,714286 | 11/02/2026 | 12,50% | 90,56% | ***** |
| JPM TAIWAN C (DIST) USD | RVI CHINA | 300,000000 | 11/02/2026 | 12,49% | 80,13% | ***** |
| JPM TAIWAN D (ACC) USD | RVI CHINA | 45,319328 | 11/02/2026 | 12,25% | 80,34% | ***** |
| JPM TAIWAN I (ACC) EUR | RVI CHINA | 367,550000 | 11/02/2026 | 12,66% | 91,75% | ***** |
| JPM TAIWAN I (ACC) USD | RVI CHINA | 310,865546 | 11/02/2026 | 12,49% | 90,81% | ***** |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) CHF (HEDGED) | BIOTECNOLOGÍA | 108,750960 | 19/02/2026 | 6,07% | 6,06% | ** |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 107,670000 | 19/02/2026 | 4,15% | 4,20% | ** |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) USD | BIOTECNOLOGÍA | 99,744746 | 19/02/2026 | 4,57% | -1,00% | * |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) CHF (HEDGED) | BIOTECNOLOGÍA | 108,685163 | 19/02/2026 | 6,08% | 6,02% | ** |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) EUR (HEDGED) | BIOTECNOLOGÍA | 107,180000 | 19/02/2026 | 4,16% | 3,99% | ** |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) USD | BIOTECNOLOGÍA | 99,268272 | 19/02/2026 | 4,56% | -1,23% | * |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) CHF (HEDGED) | BIOTECNOLOGÍA | 112,512337 | 19/02/2026 | 6,16% | 7,82% | ** |